TITLE

Calm Your Busy Bladder

PUB. DATE
September 2013
SOURCE
Cleveland Clinic Men's Health Advisor;Sep2013, Vol. 15 Issue 9, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers new treatments and lifestyle changes that can help one's overactive bladder (OAB) to relax. The causes and treatments of OAB, which is defined as the need to urinate eight or more times a day or twice or more at night, along with an inability to delay urination is mentioned. The approval of the U.S. Food and Drug Administration (FDA) on onabotulinum toxin A (Botox) for treating OAB that does not respond to anticholinergic medications is mentioned.
ACCESSION #
89768079

 

Related Articles

  • FDA makes unprecedented Rx-to-OTC switches.  // Drug Store News;3/17/2014, Vol. 36 Issue 3, p22 

    The article reports on the approval by the U.S. Food and Drug Administration (FDA) for prescription drugs to be over-the-counter drugs (OTC) medicines. It mentions that pharmaceutical company Merck & Co. Inc.'s Oxytrol for the relief of overactive bladder in women is the first of the two of the...

  • Mirabegron: Beta-3 agonist approved for OAB. Tanzi, Maria G. // Pharmacy Today;Aug2012, Vol. 18 Issue 8, p34 

    The article reports that the U.S. Food and Drug Administration (FDA) approved the usage of mirabegron for the treatment of overactive bladder (OAB) in adults with urinary incontingency and frequency. The approval of mirabegron was on data from placebo-controlled and double-blind clinical trials....

  • Overactive bladder, under scrutiny, gets a new treatment. Opar, Alisa // Nature Medicine;Aug2012, Vol. 18 Issue 8, p1159 

    The article presents information related to the patients diagnosed with overactive bladder, which is the strong, sudden need to urinate due to bladder spasms or contractions. Myrbetriq (mirabegron), a drug to treat overactive bladder, by Astellas Pharma Inc., got approval by the U.S. Food and...

  • New drug treats overactive bladder without drying mouth. LoBuono, Charlotte // Drug Topics;1/10/2005, Vol. 149 Issue 1, p18 

    This article reports on the approval of solifenacin for the treatment of overactive bladder with symptoms of urgency, urinary frequency, and urge urinary incontinence by the U.S. Food and Drug Administration. According to physician Peter Sand, a professor of obstetrics and gynecology and...

  • FDA Approves Cimzia to Treat Crohn's Disease.  // Pharmaceutical Processing;May2008, Vol. 23 Issue 5, p47 

    The article reports on the approval of Cimzia, a treatment for adults with moderate to severe Crohn's disease, by the Food and Drug Administration (FDA) in the U.S. Crohn's disease is a chronic, inflammatory bowel disease which causes diarrhea, fever or rectal bleeding. It is considered to be a...

  • Paroxetine Capsules (Brisdelleâ„¢). Elliott, William T.; Chan, James // Internal Medicine Alert;7/29/2013, Vol. 35 Issue 14, p110 

    The article focuses on a study that was conducted to examine the efficacy and safety of paroxetine for the treatment of vasomotor symptoms in postmenopausal women.

  • Trospium Chloride (Sanctura®) - New to the U.S. for Overactive Bladder. Gaines, Kaye K. // Urologic Nursing;Feb2005, Vol. 25 Issue 1, p64 

    Focuses on the approval given to the trospium chloride, an anticholinergic agent, from Indevus Pharmaceuticals by the U.S. Food and Drug Administration for the treatment of overactive bladder and its associated symptoms of urinary urgency, frequency, and incontinence. Estimation of the...

  • Deciding Between Sacral Neuromodulation and Botulinum Toxin Injections for Refractory Idiopathic Overactive Bladder. Clements, J. Quentin // AUANews;Aug2012, Vol. 17 Issue 8, p19 

    The article focuses on the choosing between sacral neuromodulation (SNM) and botulinum toxin (BTX) for the treatment of patients who failed to respond to more conservative therapies. The U.S. Food and Drug Administration has approved InterStim as the only SNM device as of 2012 while for BTX,...

  • HEALTH NEWS. BOONE, SHARON // Essence (Time Inc.);Dec2013, Vol. 44 Issue 8, p154 

    The article covers issues related to health as of December 2013. A study by the Prevention Research Center and Arizona State University discusses the relationship between liquor consumption and domestic violence. The U.S. Food and Drug Administration (FDA) has approved the use of botox for...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics